Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
Inpharmatis Team is pleased to announce that dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI 2024 from October 8 to 10 at Milan in Italy.
We look forward to meeting you and exploring new opportunities for collaboration together with our expertise in the following areas:
- Regulatory Affairs & Market Access
- API GMP audits, EU and EAEU GMP inspection support
- Pharmacovigilance services in the CIS regions
Contact us to book a time slot for a meeting: sales@inpharmatis.com
Looking forward to meeting you in Milan!
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024
Особенности процедуры пользовательского тестирования листка-вкладыша в Казахстане
May 28, 2024
Peculiarities of PIL Readability User Testing Procedure in Kazakhstan
May 28, 2024
Требования к клиническим испытаниям при регистрации медицинских изделий в России
May 21, 2024
Clinical Trials Requirements for Medical Device Registration in Russia
May 21, 2024
Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024
Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024